Kaposiform Hemangioendothelioma Presenting as Hydrops Fetalis.

Elena Sobrino-FernándezMinia Campos-DominguezRebeca Gregorio-HernándezJorge Huerta-AragonésCristina Beléndez-BielerÁngel Lancharro-ZapataMaría Luisa Franco-FernándezBelén Bernardo-AtienzaManuel Sánchez-Luna

Published in: Pediatric dermatology (2017)

We describe the case of a 33-week preterm infant who developed nonimmune hydrops fetalis secondary to a kaposiform hemangioendothelioma (KHE). The tumor was successfully treated with vincristine, prednisone, ticlopidine, and aspirin. KHE can be an unusual cause of hydrops fetalis; in such cases, diagnosis can be challenging since generalized edema can obscure KHE.

Keyphrases

low dose
preterm birth
cardiovascular events
low birth weight
clinical trial
randomized controlled trial
cardiovascular disease
coronary artery disease
preterm infants
double blind